Cargando…

Allosteric Modulators of Metabotropic Glutamate Receptors as Novel Therapeutics for Neuropsychiatric Disease

Metabotropic glutamate (mGlu) receptors, a family of G-protein-coupled receptors, have been identified as novel therapeutic targets based on extensive research supporting their diverse contributions to cell signaling and physiology throughout the nervous system and important roles in regulating comp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luessen, Deborah J., Conn, P. Jeffrey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society for Pharmacology and Experimental Therapeutics 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553119/ https://www.ncbi.nlm.nih.gov/pubmed/35710132 http://dx.doi.org/10.1124/pharmrev.121.000540

Ejemplares similares

Targeting metabotropic glutamate receptors for novel treatments of schizophrenia
por: Maksymetz, James, et al.
Publicado: (2017)

Negative Allosteric Modulators of Metabotropic Glutamate Receptors Subtype 5 in Addiction: a Therapeutic Window
por: Mihov, Yoan, et al.
Publicado: (2016)

Conformational fingerprinting of allosteric modulators in metabotropic glutamate receptor 2
por: Liauw, Brandon Wey-Hung, et al.
Publicado: (2022)

Allosteric Molecular Switches in Metabotropic Glutamate Receptors
por: Orgován, Zoltán, et al.
Publicado: (2020)

Identification of Allosteric Modulators of Metabotropic Glutamate 7 Receptor Using Proteochemometric Modeling
por: Tresadern, Gary, et al.
Publicado: (2017)

Therapeutic Potential of Metabotropic Glutamate Receptor Modulators
por: Hovelsø, N, et al.
Publicado: (2012)

Tetrahydronaphthyridine and Dihydronaphthyridinone Ethers As Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 5 (mGlu(5))
por: Turlington, Mark, et al.
Publicado: (2014)

Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5
por: Kampen, Stefanie, et al.
Publicado: (2022)

Preferential binding of allosteric modulators to active and inactive conformational states of metabotropic glutamate receptors
por: Yanamala, Naveena, et al.
Publicado: (2008)

Conformational dynamics between transmembrane domains and allosteric modulation of a metabotropic glutamate receptor
por: Gutzeit, Vanessa A, et al.
Publicado: (2019)

Therapeutic promise and principles: Metabotropic glutamate receptors
por: Maiese, Kenneth, et al.
Publicado: (2008)

Positive Allosteric Modulators of Type 5 Metabotropic Glutamate Receptors (mGluR5) and Their Therapeutic Potential for the Treatment of CNS Disorders
por: Cleva, Richard M., et al.
Publicado: (2011)

Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington's disease
por: Doria, JG, et al.
Publicado: (2013)

Selective Negative Allosteric Modulation Of Metabotropic Glutamate Receptors – A Structural Perspective of Ligands and Mutants
por: Harpsøe, Kasper, et al.
Publicado: (2015)

Agonists and allosteric modulators promote signaling from different metabotropic glutamate receptor 5 conformations
por: Nasrallah, Chady, et al.
Publicado: (2021)

Negative allosteric modulators of metabotropic glutamate receptor 3 target the stem-like phenotype of glioblastoma
por: Wirsching, Hans-Georg, et al.
Publicado: (2020)

Recent Advances in the Modulation of Pain by the Metabotropic Glutamate Receptors
por: Mazzitelli, Mariacristina, et al.
Publicado: (2022)

In Vitro Functional Characterization of GET73 as Possible Negative Allosteric Modulator of Metabotropic Glutamate Receptor 5
por: Beggiato, Sarah, et al.
Publicado: (2018)

Analysis of positive and negative allosteric modulation in metabotropic glutamate receptors 4 and 5 with a dual ligand
por: Dalton, James A. R., et al.
Publicado: (2017)

Covalent Allosteric Probe for the Metabotropic Glutamate Receptor 2: Design, Synthesis, and Pharmacological Characterization
por: Doornbos, Maarten L. J., et al.
Publicado: (2018)

Targeting of Metabotropic Glutamate Receptors for the Development of Novel Antidepressants
por: Chaki, Shigeyuki, et al.
Publicado: (2019)

Metabotropic Glutamate Receptors for Parkinson's Disease Therapy
por: Gasparini, Fabrizio, et al.
Publicado: (2013)

Metabotropic Glutamate Receptors as Novel Therapeutic Targets on Visceral Sensory Pathways
por: Blackshaw, L. Ashley, et al.
Publicado: (2011)

Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells
por: Volpi, Claudia, et al.
Publicado: (2016)

Effect of the Metabotropic Glutamate Receptor Type 5 Negative Allosteric Modulator Dipraglurant on Motor and Non-Motor Symptoms of Parkinson’s Disease
por: Epping-Jordan, Mark P., et al.
Publicado: (2023)

Design, Synthesis and Characterization of a New Series of Fluorescent Metabotropic Glutamate Receptor Type 5 Negative Allosteric Modulators
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2020)

Metabotropic glutamate receptors as a new therapeutic target for malignant gliomas
por: Pereira, Mery Stefani Leivas, et al.
Publicado: (2017)

Emerging Trends in Pain Modulation by Metabotropic Glutamate Receptors
por: Pereira, Vanessa, et al.
Publicado: (2019)

Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson's disease
por: Duty, Susan
Publicado: (2010)

Biphasic Modulation of NMDA Receptor Function by Metabotropic Glutamate Receptors
por: O'Neill, Nathanael, et al.
Publicado: (2018)

Identification of Positive Allosteric Modulators VU0155094 (ML397) and VU0422288 (ML396) Reveals New Insights into the Biology of Metabotropic Glutamate Receptor 7
por: Jalan-Sakrikar, Nidhi, et al.
Publicado: (2014)

T39. NEURAL MECHANISMS OF METABOTROPIC GLUTAMATE RECEPTOR 3 MEDIATED ENHANCEMENT OF SYNAPTIC PLASTICITY AND COGNITION
por: Stansley, Branden, et al.
Publicado: (2018)

Investigation of allosteric modulation mechanism of metabotropic glutamate receptor 1 by molecular dynamics simulations, free energy and weak interaction analysis
por: Bai, Qifeng, et al.
Publicado: (2016)

Scaffold Hopping to Imidazo[1,2-a]pyrazin-8-one Positive Allosteric Modulators of Metabotropic Glutamate 2 Receptor
por: de Lucas, Ana I., et al.
Publicado: (2021)

Metabotropic glutamate receptors inhibit microglial glutamate release
por: McMullan, Stephen M, et al.
Publicado: (2012)

Neurobiological Insights from mGlu Receptor Allosteric Modulation
por: O’Brien, Daniel E, et al.
Publicado: (2015)

The Role of Metabotropic Glutamate Receptors in Social Behavior in Rodents
por: Zoicas, Iulia, et al.
Publicado: (2019)

Metabotropic Glutamate Receptors at Ribbon Synapses in the Retina and Cochlea
por: Klotz-Weigand, Lisa, et al.
Publicado: (2022)

Molecular Basis for Modulation of Metabotropic Glutamate Receptors and Their Drug Actions by Extracellular Ca(2+)
por: Zou, Juan, et al.
Publicado: (2017)

Optical Control of Metabotropic Glutamate Receptors
por: Levitz, Joshua, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_e2lg3f8u454selsrjcfrqs6jf2